Twelve partner institutions from the United States and Canada are collaborating to develop novel treatments to improve quality of life and long-term survival for patients fighting malignant brain tumors.
How’s this for a paradox: The better cancer centers become at keeping patients alive, the more expensive cancer care becomes. This brutal tradeoff hits harder in rural areas, where the cancer burden is higher and the investigator and clinical trial representation is lower.
